A brief introductory video explaining Micropore's unique membrane-based system
Our Unique Technology
Back to Latest News
Micropore is a partner for this conference and is looking forward to meeting leaders in the field of RNA to discuss how its unique technology can support the emerging work being done to target RNA with small molecules.
RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic. But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging. With that in mind, we can’t wait to be part of the RNA Leaders USA Congress this October.
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.